European Patent Office

T 0755/96 (Camptothecin derivatives/RESEARCH TRIANGLE INSTITUTE) du 06.08.1999

Identifiant européen de la jurisprudence
ECLI:EP:BA:1999:T075596.19990806
Date de la décision
6 août 1999
Numéro de l'affaire
T 0755/96
Requête en révision de
-
Numéro de la demande
90310085.7
Classe de la CIB
C07D 491/22
Langue de la procédure
Anglais
Distribution
Publiées au Journal officiel de l'OEB (A)
Téléchargement
Décision en anglais
Autres décisions pour cet affaire
-
Résumés pour cette décision
-
Titre de la demande
Analogue de la 10,11-méthylènedioxy-20(RS)camptothécine et de la 10,11-méthylènedioxy-20(s)-camptothécine
Nom du demandeur
RESEARCH TRIANGLE INSTITUTE
Nom de l'opposant
-
Chambre
3.3.01
Sommaire

In ex parte proceedings, Rule 71a EPC gives the Examining Division a discretion to admit or refuse amended claims until a decision is issued under Article 97 EPC. This discretion must be exercised by considering all relevant factors which arise in a particular case and by balancing the Applicant's interest in obtaining a proper patent protection for his claimed invention and the EPO's interest in bringing the examination procedure to a speedy close by the issue of a decision. If in exercising said discretion amended claims are not admitted, the reasons therefore must be given. The assessment that they were filed too late under Rule 71a EPC does not represent an adequate reasoning in conformity with Rule 68(2) EPC.

Mots-clés
Discretion to admit or refuse amended claims under Rule 71a EPC (yes)
Adequate reasons for not admitting amended claims (no)
Substantial procedure violation (yes)
Reimbursement of the appeal fee (yes)
Remittal to the first instance for further prosecution
Exergue
-

ORDER

For these reasons, it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the Examining Division for further prosecution.

3. The request for reimbursement of the appeal fee is allowed.